NCT06601803

Surgiphor Us in TSA

Enrolling by Invitation
PHASE4Ages 18+InterventionalPrevention
Rothman Institute Orthopaedics
~126 participants
Updated 2024-09-19 on ClinicalTrials.gov
What's tested:sterile saline solutionSurgiphorSample Collection

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Reduction or elimination of bacteria
Measured over 90 days
Total Shoulder Arthroplasty
Shoulder Infection
Povidone Iodine

NCT06601803

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Rothman Orthopaedic Institute

    Philadelphia, Pennsylvaniano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults age \>18 years
Participants undergoing elective primary total shoulder arthroplasty
Participants willing to provide written consent

Exclusion

History of prior surgery to the operative shoulder
Known allergy to povidone iodine, iodine or shellfish
active clinical infection
participation in other clinical trials
  • Reduction or elimination of bacteria90 days

    To determine the rate of reduction of positive cultures collected before and after wound irrigation with either Surgiphor or sterile normal saline during primary total shoulder arthroplasty participants will be followed to watch for clinical signs of infection.